Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese.
Ariyoshi, Noritaka
Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. [electronic resource] - Drug metabolism and pharmacokinetics 2010 - 298-306 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1880-0920
10.2133/dmpk.25.298 doi
Aryl Hydrocarbon Hydroxylases--genetics
Biotransformation--genetics
Case-Control Studies
Chemical and Drug Induced Liver Injury--epidemiology
Cytochrome P-450 CYP2B6
Enzyme Activation--drug effects
Genotype
HLA Antigens--genetics
Haplotypes--genetics
Humans
Japan--epidemiology
Oxidoreductases, N-Demethylating--genetics
Platelet Aggregation Inhibitors--adverse effects
Polymorphism, Single Nucleotide
Ticlopidine--adverse effects
Enhanced susceptibility of HLA-mediated ticlopidine-induced idiosyncratic hepatotoxicity by CYP2B6 polymorphism in Japanese. [electronic resource] - Drug metabolism and pharmacokinetics 2010 - 298-306 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1880-0920
10.2133/dmpk.25.298 doi
Aryl Hydrocarbon Hydroxylases--genetics
Biotransformation--genetics
Case-Control Studies
Chemical and Drug Induced Liver Injury--epidemiology
Cytochrome P-450 CYP2B6
Enzyme Activation--drug effects
Genotype
HLA Antigens--genetics
Haplotypes--genetics
Humans
Japan--epidemiology
Oxidoreductases, N-Demethylating--genetics
Platelet Aggregation Inhibitors--adverse effects
Polymorphism, Single Nucleotide
Ticlopidine--adverse effects